- Home
- HCM vs CALX Comparison
HCM vs CALX Comparison
Compare HCM & CALX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HCM
- CALX
- Stock Information
- Founded
- HCM 2000
- CALX 1999
- Country
- HCM Hong Kong
- CALX United States
- Employees
- HCM N/A
- CALX N/A
- Industry
- HCM Biotechnology: Pharmaceutical Preparations
- CALX Telecommunications Equipment
- Sector
- HCM Health Care
- CALX Consumer Discretionary
- Exchange
- HCM Nasdaq
- CALX Nasdaq
- Market Cap
- HCM 2.6B
- CALX 2.5B
- IPO Year
- HCM N/A
- CALX 2010
- Fundamental
- Price
- HCM $14.20
- CALX $37.89
- Analyst Decision
- HCM Hold
- CALX Strong Buy
- Analyst Count
- HCM 1
- CALX 6
- Target Price
- HCM $19.00
- CALX $42.50
- AVG Volume (30 Days)
- HCM 76.1K
- CALX 431.3K
- Earning Date
- HCM 02-26-2025
- CALX 01-29-2025
- Dividend Yield
- HCM N/A
- CALX N/A
- EPS Growth
- HCM N/A
- CALX N/A
- EPS
- HCM N/A
- CALX N/A
- Revenue
- HCM $610,806,000.00
- CALX $890,128,000.00
- Revenue This Year
- HCM N/A
- CALX N/A
- Revenue Next Year
- HCM $20.69
- CALX $3.13
- P/E Ratio
- HCM N/A
- CALX N/A
- Revenue Growth
- HCM N/A
- CALX N/A
- 52 Week Low
- HCM $11.93
- CALX $26.76
- 52 Week High
- HCM $21.92
- CALX $45.15
- Technical
- Relative Strength Index (RSI)
- HCM 42.32
- CALX 61.35
- Support Level
- HCM $13.00
- CALX $37.09
- Resistance Level
- HCM $15.29
- CALX $38.66
- Average True Range (ATR)
- HCM 0.46
- CALX 1.30
- MACD
- HCM -0.00
- CALX 0.19
- Stochastic Oscillator
- HCM 37.74
- CALX 84.35
About HCM HUTCHMED (China) Limited
HUTCHMED (China) Ltd is an innovative biopharmaceutical company engaged in the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.
About CALX Calix Inc
Calix Inc develops, market and sell Calix cloud, systems and software platforms to enable service providers of all types and sizes to innovate and transform. The company's customers utilize the real-time data and insights from Calix platforms to simplify their business and deliver experiences that excite their subscribers. The resulting growth in subscriber acquisition, loyalty and revenue creates more value for their businesses and communities. The Company's revenue is principally derived in the United States and it also has its presence in Middle East & Africa, Europe, Asia Pacific and other markets.